AP
Advisor Partners’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $383K | Buy |
1,790
+252
| +16% | +$53.9K | 0.03% | 563 |
|
|
2022
Q1 | $437K | Buy |
1,538
+7
| +0.5% | +$1.99K | 0.03% | 557 |
|
|
2021
Q4 | $577K | Sell |
1,531
-16
| -1% | -$6.03K | 0.03% | 475 |
|
|
2021
Q3 | $638K | Sell |
1,547
-84
| -5% | -$34.6K | 0.04% | 413 |
|
|
2021
Q2 | $603K | Buy |
1,631
+53
| +3% | +$19.6K | 0.04% | 444 |
|
|
2021
Q1 | $457K | Buy |
1,578
+21
| +1% | +$6.08K | 0.03% | 499 |
|
|
2020
Q4 | $389K | Buy |
1,557
+44
| +3% | +$11K | 0.03% | 517 |
|
|
2020
Q3 | $343K | Sell |
1,513
-197
| -12% | -$44.7K | 0.03% | 490 |
|
|
2020
Q2 | $298K | Buy |
1,710
+25
| +1% | +$4.36K | 0.03% | 519 |
|
|
2020
Q1 | $212K | Sell |
1,685
-114
| -6% | -$14.3K | 0.03% | 532 |
|
|
2019
Q4 | $286K | Sell |
1,799
-76
| -4% | -$12.1K | 0.03% | 506 |
|
|
2019
Q3 | $248K | Buy |
1,875
+20
| +1% | +$2.65K | 0.03% | 541 |
|
|
2019
Q2 | $263K | Sell |
1,855
-102
| -5% | -$14.5K | 0.03% | 501 |
|
|
2019
Q1 | $284K | Sell |
1,957
-166
| -8% | -$24.1K | 0.04% | 468 |
|
|
2018
Q4 | $240K | Buy |
2,123
+72
| +4% | +$8.14K | 0.04% | 474 |
|
|
2018
Q3 | $276K | Sell |
2,051
-6
| -0.3% | -$807 | 0.04% | 485 |
|
|
2018
Q2 | $231K | Buy |
2,057
+156
| +8% | +$17.5K | 0.04% | 494 |
|
|
2018
Q1 | $203K | Sell |
1,901
-254
| -12% | -$27.1K | 0.04% | 527 |
|
|
2017
Q4 | $233K | Buy |
2,155
+4
| +0.2% | +$432 | 0.04% | 482 |
|
|
2017
Q3 | $232K | Buy |
2,151
+94
| +5% | +$10.1K | 0.05% | 421 |
|
|
2017
Q2 | $208K | Buy |
+2,057
| New | +$208K | 0.05% | 435 |
|